ARVTAntiretroviral Therapy (HIV/AIDS prevention and treatment)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Furthermore, most patients with TB/HIV coinfection are treated for tuberculosis in a primary care facility, but receive ARVT in another facility, generally at the secondary or tertiary level.
No information integrated with the tuberculosis strategy on coinfected patients who receive ARVT was found, since they tend to be served in different health facilities.
These barriers have also been found to have effects on indicators, such as IPT coverage in patients with HIV and high mortality in patients with coinfection, in addition to the lack of data for constructing indicators, such as ARVT coverage in patients with tuberculosis.
Furthermore, women who were receiving ARVT during pregnancy and did not use prophylaxis during labor, as well as women who were aware of their HIV status before pregnancy and had not undergone Cesarean delivery raises the issue of communication among HIV care services, antenatal care, maternity services, and the involved woman.
He had been diagnosed with HIV-infection 5 years previously and had been on ARVT for about 2 years.
He continues taking his ARVT as well as using protection to avoid infecting his girlfriend.
Moreover, it has been described that ARVT normalizes the production cell progenitors, induces change in T cell subtypes, reverses the defects of DC[4.sup.+] cells, and restores the production of cytokines, such as IL-2, and the reactivation of lymphocytes [17].
(20) reported that by means of PCR multiple TLRs are increased in untreated, chronic HIV infection, and that this effect is reversed when viral replication is inhibited after ARVT, suggesting that viral replication leads to increased in vivo expression of TLR.
Such donations were indeed relied upon in the 1990s; however, by the time of d'Adesky's report, Cuba had 100% free ARVT coverage (5).
In 1996, after the Worlds AIDS conference and the recommendation of HAART, Cuba purchased ARVT drugs for all children with AIDS and their mothers, at a cost of US$ 14 000 per person per year.
The inclusion criteria were being 18 years of age or older, having been diagnosed with HIV/ AIDS for longer than 6 months, using ARVT, having no neurological or psychiatric disorders and not being pregnant.
Disease length was considered the difference between the date of diagnosis and the date of the interview, and the length of ARVT use was the difference between the start dates of use recorded in the medical charts and the date of the interview.